InicioCarterasWatchlistComunidadDescubreScreener
NOT FOR DISTRIBUTION

Corteva, Inc.

Informe acción NYSE:CTVA

Capitalización de mercado: US$56.0b

  • Resumen empresa
  • Valoración
  • Crecimiento Futuro
  • Rendimiento pasado
  • Salud Financiera
  • Dividendos
  • Dirección
  • Propiedad
  • Información adicional
  • Comunidad de acciones

Corteva Dividendos y recompras

Dividendo controles de criterios 2/6

Corteva es una empresa que paga dividendos con una rentabilidad actual de 0.86% que está bien cubierta por los beneficios. La próxima fecha de pago es en 15th September, 2026 con una fecha ex dividendo de 1st September, 2026.

Información clave

0.9%

Rentabilidad por dividendo

1.8%

Rendimiento de la recompra

Rendimiento total para el accionista2.6%
Rendimiento futuro de los dividendos1.0%
Crecimiento de los dividendos9.4%
Próxima fecha de pago de dividendos15 Sep 26
Fecha ex dividendo01 Sep 26
Dividendo por acciónn/a
Ratio de pago45%

Últimas actualizaciones de dividendos y recompras

Recent updates

User avatar
Actualización de narrativa • Aug 04

CTVA: Upcoming Seed Spinoff And Crop Protection Pipeline Will Reshape Earnings Mix

Analysts lifted their price target for Corteva to $92.40 from $90.05, pointing to updated expectations around the Vylor seed spinoff, the crop protection and fertilizer backdrop, and the revised P/E and profitability assumptions cited in recent research. Analyst Commentary Recent research on Corteva centers on how the Vylor seed spinoff, crop protection trends, and fertilizer market conditions may affect valuation, growth prospects, and execution risk.
Seeking Alpha • Jul 31

Corteva: Strong Fundamentals, Limited Upside

Summary Corteva, Inc. stands as a global leader in pure agri-tech, emphasizing R&D for advanced seed genetics and sustainable crop solutions. My prior Hold ratings on CTVA underestimated the market's preference for quality, execution, and improved business visibility over strict valuation metrics. CTVA has significantly outperformed the broader market by four times and its ETF peers by more than two times since my earlier reviews. The investment thesis now centers on CTVA's superior execution and enhanced operational visibility as key drivers of its recent outperformance. Read the full article on Seeking Alpha
Artículo de análisis • Jun 20

Corteva (CTVA) Stock Could Be 13% Undervalued After FMC Herbicide Deal

Why the new FMC partnership matters for Corteva stock Corteva (CTVA) recently signed a multi-year, co-exclusive supply and license agreement with FMC Corporation for rimisoxafen herbicide technology, giving the company another tool in corn and soybean crop protection. The deal covers North and South American markets, includes a US$200 million prepurchase payment from Corteva, and allows both companies to create their own premix formulations. Commercial sales are targeted by the end of the...
User avatar
Actualización de narrativa • Jun 14

CTVA: Upcoming Spin Focused On Seed And Crop Protection Will Reshape Earnings Mix

Corteva's updated analyst price target edges higher by about $0.14 to roughly $90.05, as analysts refine their assumptions around revenue growth, profit margins and future P/E in light of recent target increases across the Street for the upcoming spin focused on seed and crop protection businesses. Analyst Commentary Recent research updates around Corteva cluster around the upcoming spin of its seed and crop protection businesses, with a series of higher price targets reflecting refreshed views on growth, execution and valuation for what some refer to as "New Corteva." Bullish analysts point to recalibrated assumptions on revenue, margins and P/E, while more cautious voices focus on whether the standalone company can consistently deliver against those expectations once separated.
User avatar
Actualización de narrativa • May 31

CTVA: SpinCo Separation And Biofungicide Collaboration Will Reshape Future Earnings Mix

The analyst price target for Corteva is updated to $89.90 from $86.05 as analysts note that the market is treating "New Corteva" like a no-growth commodity chemical company. They instead highlight expectations for a healthier standalone growth profile, modestly higher profit margins, and a slightly lower assumed future P/E multiple.
Artículo de análisis • May 14

Corteva's (NYSE:CTVA) Performance Is Even Better Than Its Earnings Suggest

Even though Corteva, Inc.'s ( NYSE:CTVA ) recent earnings release was robust, the market didn't seem to notice...
User avatar
Actualización de narrativa • Apr 27

CTVA: Fair Value View Weighs Crop Protection Uncertainty And Planned SpinCo Separation

Corteva's analyst price target has increased by about $2, as analysts cite updated earnings models, a revised fair value of $86.05, a slightly adjusted discount rate, and modest changes to revenue growth, profit margin, and future P/E assumptions. Analyst Commentary Street research on Corteva has been active, with several price target revisions and a mix of ratings changes that give you both supportive and cautious signals to weigh.
User avatar
Actualización de narrativa • Apr 13

CTVA: Fair Value View Balances Crop Protection Risks And Upcoming SpinCo Separation

The analyst price target for Corteva has moved modestly higher to align with a fair value estimate of about $84, as analysts factor in updated earnings models, slightly adjusted revenue growth and profit margin assumptions, and recent price target changes across several firms. Analyst Commentary Recent Street research on Corteva shows a mix of higher price targets and a few rating downgrades, so you are seeing both optimism and caution reflected in the current analyst debate.
User avatar
Actualización de narrativa • Mar 28

CTVA: Crop Protection Uncertainty And SpinCo Separation Will Shape Future Risk Balance

The analyst price target for Corteva has been nudged higher, with a modest fair value uplift to $83.95 as analysts balance a series of recent target increases from multiple firms against more cautious views tied to softer crop protection trends. Analyst Commentary Recent research on Corteva reflects a split view, with several firms lifting price targets while others turn more cautious on near term fundamentals, especially in crop protection.
User avatar
Actualización de narrativa • Mar 12

CTVA: Mixed Crop Protection Outlook And New SpinCo Plan Will Shape Risk Balance

The analyst price target for Corteva edges higher to $83.33 from $82.76, as analysts factor in slightly firmer long term revenue growth and profit margins, while balancing more cautious views on crop protection trends and a modestly lower discount rate. Analyst Commentary Recent research on Corteva reflects a split view, with several firms lifting price targets while others turn more cautious on execution in crop protection.
User avatar
Actualización de narrativa • Feb 26

CTVA: Sector Uncertainty And New Ventures Will Shape Forward Risk Balance

Corteva's analyst fair value estimate has edged up to $82.76 from $82.05 as analysts refine their models and price targets following recent earnings updates and a broad wave of upward target revisions across the Street. Analyst Commentary Recent Street research around Corteva reflects an active debate, with several firms adjusting price targets and a mix of upgrades and downgrades around the latest earnings update.
User avatar
Actualización de narrativa • Feb 11

CTVA: Mixed Sector Backdrop And New Ventures Will Shape Future Prospects

Corteva's analyst fair value estimate has increased to $82.05 from $78.43 as analysts factor in slightly stronger revenue growth assumptions, a higher future P/E multiple, and a modestly lower discount rate, even as projected profit margins are trimmed. Analyst Commentary Recent Street research on Corteva is mixed, with several bullish analysts lifting price targets while a few high profile firms turn more cautious.
User avatar
Actualización de narrativa • Jan 26

CTVA: Seed And Crop Protection Split Will Shape Balanced Future Prospects

Narrative Update Analysts have modestly raised their price expectations for Corteva, with the updated fair value estimate moving by about US$0.48 per share. This reflects slightly adjusted assumptions for discount rate, revenue growth, profit margin, and future P/E, and is supported by recent target increases from several firms.
User avatar
Actualización de narrativa • Jan 11

CTVA: Planned Seed And Pesticide Split Will Support Future Earnings Power

Analysts lifted their blended fair value estimate for Corteva by about $0.19 to roughly $77.95 per share, reflecting updated price targets that factor in a mixed backdrop for chemicals and agriculture but continued confidence in the company’s ability to increase earnings. Analyst Commentary Recent research on Corteva reflects a mix of optimism and caution, with price targets clustered in the mid to high US$70s and one outlier in the low US$80s.
User avatar
Actualización de narrativa • Dec 18

CTVA: Planned Seed And Pesticide Split Will Unlock Future Earnings Power

The analyst price target for Corteva has been nudged higher by approximately $0.05 to about $77.76, as analysts factor in a slightly lower discount rate and modestly improved long term growth expectations, despite broadly cautious sector commentary and recent target reductions. Analyst Commentary Street research on Corteva reflects a divided but generally constructive view, with price targets drifting lower but ratings remaining skewed toward positive as investors reassess the company’s post breakup trajectory and near term earnings backdrop.
User avatar
Actualización de narrativa • Dec 03

CTVA: Planned Seed And Pesticide Split Will Unlock Future Earnings Power

Our analyst price target for Corteva has been trimmed modestly in line with recent Street moves, as analysts factor in lower sector multiples and near term earnings uncertainty around the planned split, while still recognizing the company’s intact innovation engine and long term earnings growth potential. Analyst Commentary Street views on Corteva have become more bifurcated following the announced split, with valuation targets reset lower but ratings broadly supportive of the long term strategic rationale and earnings power.
Artículo de análisis • Nov 26

A Look At The Fair Value Of Corteva, Inc. (NYSE:CTVA)

Key Insights Corteva's estimated fair value is US$63.85 based on 2 Stage Free Cash Flow to Equity Current share price...
User avatar
Actualización de narrativa • Nov 19

CTVA: Upcoming Seed And Pesticide Split Will Unlock Shareholder Value

The analyst consensus price target for Corteva has been modestly reduced, slipping from approximately $77.86 to $77.71. Analysts reflect more cautious expectations for earnings growth in light of a mixed agricultural outlook and anticipated impacts from the company's planned business split.
User avatar
Actualización de narrativa • Nov 05

CTVA: Share Split Will Drive Shareholder Value Unlocking Amid Ongoing Business Realignment

Analysts have modestly reduced their average price target for Corteva by approximately $1.20. They cite a more cautious outlook amid challenging crop protection conditions and the company's recent announcement to split into two separate businesses.
User avatar
Actualización de narrativa • Oct 22

Analysts Offer Mixed Views as Corteva Eyes Split and Updates Guidance Amid Modest Valuation Shift

Analysts have modestly reduced their price target for Corteva by about $0.76 to $79.05. They cite uncertainty regarding the company’s planned split and the retention of legacy liabilities, though fundamentals and growth remain largely stable.
User avatar
Actualización de narrativa • Oct 08

High-Yield Seed Demand And Eco Policies Will Transform Agriculture

Corteva's analyst price target has been modestly reduced by $0.95 per share. Analysts cite continued uncertainty around the planned corporate split and complex crop protection market dynamics.
User avatar
Actualización de narrativa • Sep 04

High-Yield Seed Demand And Eco Policies Will Transform Agriculture

Analysts maintained their price target for Corteva at $80.76, citing margin expansion and EBITDA growth driven by successful innovation, favorable market fundamentals, and strong execution. Analyst Commentary Ongoing cost reductions, successful innovation, and strong execution are driving margin expansion and double-digit EBITDA growth.
Seeking Alpha • Apr 21

Corteva: Upgraded To Strong Buy On Tariffs, Currency Tailwinds, Strong Guidance

Summary Upgrading Corteva from Buy to Strong Buy due to macro conditions, including tariff-induced supply shocks, rising commodity prices, and currency tailwinds. Corteva's diversified supply chain and local production in seeds position it to benefit from regionalization and potential inflationary pressures in the agricultural sector. Strong Q4 earnings, record operating EBITDA margin, and robust free cash flow support the bullish outlook, with significant shareholder returns through dividends and buybacks. Improved valuation at 20x forward earnings, solid balance sheet, and technical indicators suggest potential for further upside in the current market environment. Read the full article on Seeking Alpha
Seeking Alpha • Mar 30

Pure Market Inefficiency In Corteva Preferreds Pricings

Summary This article explores a market inefficiency in fixed-income securities, specifically between Corteva's $4.50 and $3.50 Series Cumulative Preferred Stocks. We identified an arbitrage opportunity due to technical buying, making it an ideal pair trade with identical issues from the same company. On 02/09/2025, we recommended CTA-B for our investment-grade long-duration portfolio. On 02/10/2025, technical high-volume buying in CTA-A turned our initial investment idea into a pair trade. This pair trade highlights how technical factors can create profitable opportunities in fixed-income securities, especially among identical issues from the same issuer. Read the full article on Seeking Alpha

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: Aunque el pago de dividendos se ha mantenido estable, CTVA lleva pagando dividendos menos de 10 años.

Dividendo creciente: El pago de dividendos de CTVA ha aumentado, pero la empresa sólo ha pagado dividendos durante 7 años.


Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de Corteva vs. Mercado
¿Cómo se compara la rentabilidad por dividendo de CTVA con la del mercado?
SegmentoRentabilidad por dividendo
Empresa (CTVA)0.9%
Suelo de mercado 25% (US)1.4%
Techo de mercado 25% (US)4.1%
Media de la industria (Chemicals)1.8%
Analista de previsiones (CTVA) (hasta 3 años)1.0%

Dividendo destacado: El dividendo de CTVA(0.86%) no es notable en comparación con el 25% inferior de pagadores de dividendos del mercado US (1.36%).

Alto dividendo: El (0.86%) del dividendo de CTVA es bajo en comparación con el 25% de los principales pagadores de dividendos del mercado US (4.11%).


Pago de beneficios a los accionistas

Cobertura de los beneficios: Con su razonablemente bajo ratio de pago (44.7%), los pagos de dividendos de CTVA están bien cubiertos por los beneficios.


Pago en efectivo a los accionistas

Cobertura de flujo de caja: Con su actual ratio de pago en efectivo (76.4%), los pagos de dividendos de CTVA están cubiertos por los flujos de caja.


Descubre empresas que pagan buenos dividendos

7D

1Y

7D

1Y

7D

1Y

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/09/13 01:55
Precio de las acciones al final del día2026/09/11 00:00
Beneficios2026/06/30
Ingresos anuales2025/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
  • Formulario SEC 10-K
  • Formulario SEC 10-Q
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
  • Informes de análisis
  • Blue Matrix
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
  • Datos de mercado ICE
  • Formulario S-1 de la SEC
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
  • Formulario SEC 4
  • Formulario SEC 13D
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
  • Formulario SEC 10-K
  • Formulario SEC DEF 14A
Principales avances10 años
  • Anuncios de empresas
  • Formulario SEC 8-K

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Corteva, Inc. está cubierta por 34 analistas. 20 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
null nullArgus Research Company
Benjamin TheurerBarclays
Aron CeccarelliBerenberg

Toma mejores decisiones de inversión en cualquier lugar

Escanea para descargar
Abrir AppStoreAbrir Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Ver fuentes de datos
Mercados
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Ideas de inversión
  • Empresas infravaloradas
  • Potentes generadores de dividendos
  • Compras con información privilegiada
  • Energía nuclear
  • Vehículos autónomos
  • Inteligencia artificial
  • Criptomonedas y blockchain
  • Ciberseguridad
  • Más ideas
Comunidades de acciones
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Herramientas y funciones
  • Seguimiento de la cartera
  • Buscador de valores y alertas
  • Narrativas y Valores de Feria
  • Calculadora de dividendos
Noticias y descubrimientos
  • Últimas noticias de stock
  • Incidencias del mercado global
  • El Foxhole
  • Ideas de inversión
  • Narrativas de la comunidad
  • Qué hay de nuevo
Simply Wall St
  • Planes y precios
  • Publicidad
  • Quiénes somos
  • Contacte con nosotros
  • Empleos
  • Centro de ayuda
  • Aprender a invertir en bolsa
  • Programa de afiliados
  • Empresas y negocios
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Términos y condiciones de uso
  • Política de privacidad
  • Términos de IA
  • Guía de servicios financieros